Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1961 1
1965 1
1966 2
1967 2
1969 3
1970 1
1971 3
1972 3
1973 1
1974 7
1975 3
1976 9
1977 1
1978 1
1979 9
1980 7
1981 9
1982 11
1983 9
1984 12
1985 11
1986 18
1987 28
1988 34
1989 26
1990 31
1991 31
1992 29
1993 35
1994 29
1995 31
1996 38
1997 40
1998 59
1999 52
2000 51
2001 64
2002 51
2003 62
2004 75
2005 106
2006 120
2007 153
2008 138
2009 141
2010 163
2011 197
2012 195
2013 238
2014 270
2015 269
2016 286
2017 304
2018 348
2019 348
2020 438
2021 497
2022 494
2023 539
2024 260

Text availability

Article attribute

Article type

Publication date

Search Results

5,655 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapy: A promising novel endometriosis therapy.
Li W, Lin A, Qi L, Lv X, Yan S, Xue J, Mu N. Li W, et al. Among authors: lin a. Front Immunol. 2023 Apr 17;14:1128301. doi: 10.3389/fimmu.2023.1128301. eCollection 2023. Front Immunol. 2023. PMID: 37138868 Free PMC article. Review.
Algorithm for optimized mRNA design improves stability and immunogenicity.
Zhang H, Zhang L, Lin A, Xu C, Li Z, Liu K, Liu B, Ma X, Zhao F, Jiang H, Chen C, Shen H, Li H, Mathews DH, Zhang Y, Huang L. Zhang H, et al. Among authors: lin a. Nature. 2023 Sep;621(7978):396-403. doi: 10.1038/s41586-023-06127-z. Epub 2023 May 2. Nature. 2023. PMID: 37130545 Free PMC article.
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC.
Zhou C, Solomon B, Loong HH, Park K, Pérol M, Arriola E, Novello S, Han B, Zhou J, Ardizzoni A, Mak MP, Santini FC, Elamin YY, Drilon A, Wolf J, Payakachat N, Uh MK, Rajakumar D, Han H, Puri T, Soldatenkova V, Lin AB, Lin BK, Goto K; LIBRETTO-431 Trial Investigators. Zhou C, et al. Among authors: lin ab. N Engl J Med. 2023 Nov 16;389(20):1839-1850. doi: 10.1056/NEJMoa2309457. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870973 Free PMC article. Clinical Trial.
Clonal haematopoiesis and risk of chronic liver disease.
Wong WJ, Emdin C, Bick AG, Zekavat SM, Niroula A, Pirruccello JP, Dichtel L, Griffin G, Uddin MM, Gibson CJ, Kovalcik V, Lin AE, McConkey ME, Vromman A, Sellar RS, Kim PG, Agrawal M, Weinstock J, Long MT, Yu B, Banerjee R, Nicholls RC, Dennis A, Kelly M, Loh PR, McCarroll S, Boerwinkle E, Vasan RS, Jaiswal S, Johnson AD, Chung RT, Corey K, Levy D, Ballantyne C; NHLBI TOPMed Hematology Working Group; Ebert BL, Natarajan P. Wong WJ, et al. Among authors: lin ae. Nature. 2023 Apr;616(7958):747-754. doi: 10.1038/s41586-023-05857-4. Epub 2023 Apr 12. Nature. 2023. PMID: 37046084 Free PMC article.
LncRNA modulates Hippo-YAP signaling to reprogram iron metabolism.
He XY, Fan X, Qu L, Wang X, Jiang L, Sang LJ, Shi CY, Lin S, Yang JC, Yang ZZ, Lei K, Li JH, Ju HQ, Yan Q, Liu J, Wang F, Shao J, Xiong Y, Wang W, Lin A. He XY, et al. Among authors: lin a. Nat Commun. 2023 Apr 20;14(1):2253. doi: 10.1038/s41467-023-37871-5. Nat Commun. 2023. PMID: 37080959 Free PMC article.
Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer: A Phase 3 Randomized Clinical Trial.
Li N, Zhu J, Yin R, Wang J, Pan L, Kong B, Zheng H, Liu J, Wu X, Wang L, Huang Y, Wang K, Zou D, Zhao H, Wang C, Lu W, Lin A, Lou G, Li G, Qu P, Yang H, Zhang Y, Cai H, Pan Y, Hao M, Liu Z, Cui H, Yang Y, Yao S, Zhen X, Hang W, Hou J, Wang J, Wu L. Li N, et al. Among authors: lin a. JAMA Oncol. 2023 Sep 1;9(9):1230-1237. doi: 10.1001/jamaoncol.2023.2283. JAMA Oncol. 2023. PMID: 37440217 Free PMC article. Clinical Trial.
Reply.
Lin BR, Al-Khersan H, Rowsey T, West M, Lin A, Qu P, Bitrian E, Hudson J, Venincasa M, Fan J, Gutkind N, Diaz JD, Parekh P, Sultan H, Yannuzzi NA. Lin BR, et al. Among authors: lin a. Ophthalmology. 2023 Oct;130(10):e35-e36. doi: 10.1016/j.ophtha.2023.07.003. Epub 2023 Jul 10. Ophthalmology. 2023. PMID: 37437782 No abstract available.
Branchiooculofacial Syndrome.
Lin AE, Haldeman-Englert CR, Milunsky JM. Lin AE, et al. 2011 May 31 [updated 2023 Sep 28]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 2011 May 31 [updated 2023 Sep 28]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 21634087 Free Books & Documents. Review.
Doing More with Less.
Lin AA, Fulkerson PC. Lin AA, et al. NEJM Evid. 2023 Nov;2(11):EVIDe2300223. doi: 10.1056/EVIDe2300223. Epub 2023 Oct 24. NEJM Evid. 2023. PMID: 38320531
5,655 results